Antimetastatic and anticancer activity of S-1, a new oral dihydropyrimidine-dehydrogenase-inhibiting fluoropyrimidine, alone and in combination with paclitaxel in an orthotopically implanted human breast cancer model.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples